These results of up-regulation of HO-1 by EF24 suppressing GPX4 expression and triggering ferroptosis indicate that EF24 may serve as a promising agent for the treatment of patients with HO-1-positive osteosarcoma. Here, HMOX1 is linked to osteosarcoma.